SP 500 Edges Higher as Healthcare and Technology Lead Communication Services Lags Jamie Dimon Signals Potential Challenges for JPMorgan Bankers Amid Economic Uncertainty Bond Market Signals Inflation Concerns as Warsh Assumes Federal Reserve Leadership Visa Highlights How AI Is Amplifying Financial Scams in Latest Threats Report PutinXi Talks Revive Stalled Power of Siberia 2 Pipeline Amid Iran War Energy Market Turmoil Meta Tests AI Subscription Plans Starting at 799 Monthly Signaling New Revenue Stream WaFd Inc WAFDP Q1 2026 Earnings EPS Beats Estimates Amid Solid Operational Performance IMNM Q1 2026 Earnings SmallerthanExpected Loss as Pipeline Progress Continues FITBM Q1 2026 Earnings Strong EPS Surprise of 35 Driven by Solid Operating Performance VC Q1 2026 Earnings EPS Beat Surprises Market Shares Jump 29 Seabridge Gold SA Q1 2024 Earnings DevelopmentStage Miner Posts Net Loss No Revenue as KSM Project Advances GSK Q1 2026 Earnings EPS Surpasses Estimates with 384 Surprise HCMAW Warrants Hold Steady at 059 Amid Low Volatility Global Self Storage SELF Slips Modestly Support Near 489 Remains Key Ebang International Holdings EBON Gains 245 as Shares Test Key Resistance Level Bradesco BBD Slides 11 Support Level in Focus as Brazilian Banking Sector Digests Volatility Howmet Aerospace HWM Gains 164 as Aerospace Demand Lifts Shares Toward Resistance EWBC Q1 2026 Earnings EPS Surpasses Estimates Amid Solid Operating Performance Carter Bankshares Inc CARE Q1 2026 Earnings EPS Misses Estimates by Wide Margin Despite Positive Stock Reaction LGCY Q1 2026 Earnings EPS Beats Estimates by 244 Revenue Not Disclosed ACT Q1 2026 Earnings EPS Beats Estimates as Enact Holdings Posts Solid Underwriting Results ArcelorMittal MT Q1 2026 Earnings Modest EPS Beat Amid Market Uncertainties VSE Corporation Tangible Equity Units VSECU Q1 2026 Earnings Strong Earnings Beat Amid Modest Stock Decline Disneys The Mandalorian and Grogu Posts Lowest Thursday Preview Sales in Star Wars Franchise History IPHA Q1 2026 Earnings WiderThanExpected Losses on Zero Revenue Beam Therapeutics BEAM Edges Higher as Investors Weigh Gene Editing Sector Outlook